EnilloRing NDC 70700-156

NDC codes

FDA NDC Directory

Product NDC (as listed)70700-156Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70700-0156Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70700-156-91	70700015691	3 POUCH in 1 CARTON (70700-156-91) / 21 d in 1 POUCH (70700-156-11)Marketed from Aug 15, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): EnilloRing
Generic name (nonproprietary): etonogestrel and ethinyl estradiol vaginal
Active ingredients: Ethinyl estradiol — .015 mg/dEtonogestrel — .12 mg/d
Dosage form: Ring
Route: Vaginal
Labeler: Xiromed, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211157
Marketing start: Aug 15, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Estrogen Receptor Agonists (Mechanism)Progesterone Congeners (Chemical structure)
Identifiers: Product ID 70700-156_fdcf9082-3f49-2942-cc4b-d92d88df2dbcSPL ID fdcf9082-3f49-2942-cc4b-d92d88df2dbcSPL set ID 85a126f6-d3e0-9e12-73f9-6176ba36f58bRxCUI 1367436, 2644707UNII 423D2T571U, 304GTH6RNHUPC 0370700156919
Pharmacologic class: Estrogen; Progestin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N470700015691 followed by a unit qualifier and the quantity

Package 70700-0156-91. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 24, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

FOR VAGINAL USE ONLY EnilloRing is indicated for use by females of reproductive age to prevent pregnancy. EnilloRing is an estrogen/progestin combination hormonal contraceptive (CHC) indicated for use by women to prevent pregnancy. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211157

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211157
Product	Strength	Form · route	Labeler	Product NDC
Etonogestrel and Ethinyl Estradiol Vaginal Ring	Ethinyl estradiol .015 mg/d; Etonogestrel .12 mg/d	RingVaginal	Northstar Rx LLC	16714-029
Etonogestrel and Ethinyl Estradiol Vaginal	Ethinyl estradiol .015 mg/d; Etonogestrel .12 mg/d	RingVaginal	AvKARE	42291-478